|
On 06/06/2023, infutronix received a report that the pump kept shutting off.There was no patient injury reported.Subsequent information received on 06/07/2023 indicated the medication to be infused was fluorouracil at a volume of 92ml.However, there was a delay in therapy since the pump would automatically shut off without an audible sound or visible error message, and the infusion could not be started.The pump in question was set aside, and the therapy was successfully administered with another pump.The pump in question was not available for return at the initial time that the event was reported, and the complaint file was closed.On 05/17/2024, the pump was returned to infutronix for evaluation with reference to this event.The reportability decision was re-evaluated and determined to be 30-day reportable to fda.
|